carbon monoxide has been researched along with ritonavir in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahamed, J; Choi, ME; Elhadad, S; Ghafoory, S; Laurence, J; Robison, T; Terry, H; Varshney, R; Woolington, S | 1 |
1 other study(ies) available for carbon monoxide and ritonavir
Article | Year |
---|---|
HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-β1 and can be suppressed by exogenous carbon monoxide.
Topics: Animals; Blood Platelets; Carbon Monoxide; Cardiac Output; Echocardiography; Fibrosis; Heart Diseases; HIV Protease Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Ritonavir; Stroke Volume; Transforming Growth Factor beta1 | 2017 |